Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by EurekaTraderon Nov 21, 2016 8:24pm
95 Views
Post# 25492790

RE:CEO sold 2 million shares already?

RE:CEO sold 2 million shares already?So wait .... You read that NR but not this one?

Mr. Carman Parente reports

EARLY WARNING REPORT

Carman Parente, president and chief executive officer of New Age Farm Inc., has received eight million shares of New Age Farm as compensation for services provided to the issuer at a deemed price of 7.125 cents per share and subscribed for a further two million shares at a price of 8.5 cents per unit share as part of the issuer's recently closed private placement (see the issuer's news release dated Oct. 16, 2016), and has thereby acquired ownership and control over an additional 10 million common shares. These shares are in addition to the 16,060,565 shares he already owned prior to the transaction. Immediately after the transaction, Mr. Parente owned 26,060,565 or 26.65 per cent of the issued and outstanding common shares of the issuer. The shares were acquired for investment purposes, and, depending on market and other conditions, Mr. Parente may from time to time in the future increase or decrease his ownership, control or direction over securities of the issuer through market transactions, private agreements or otherwise. Mr. Parente has filed on SEDAR a report in accordance with National Instrument 62-103.

We seek Safe Harbor.

© 2016 Canjex Publishing Ltd. All rights reserved.

Bullboard Posts